Skip to main content
. 2014 Sep;69(9):615–620. doi: 10.6061/clinics/2014(09)07

Table 2.

Distribution of patients according to their CHADS2, CHA2DS2VASc and HAS-BLED scores.

Score Score of risk (n (%))
CHADS2 CHA2DS2VASc HAS-BLED
0 8 (4.9) 2 (1.2) 7 (4.3)
1 13 (8.0) 5 (3.1) 48 (29.6)
2 50 (30.9) 12 (7.4) 73 (45.1)
3 39 (24.1) 40 (24.7) 31 (19.1)
4 29 (17.9) 24 (14.8) 3 (1.9)
5 15 (9.3) 33 (20.4) 0 (0.0)
6 8 (4.9) 25 (15.4) 0 (0.0)
7 - 15 (9.3)
8 - 6 (3.7)